Growth Metrics

Merck (MRK) Property, Plant & Equipment (Net) Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6.81%
Dec 31, 2025 8.29%
Sep 30, 2025 8.67%
Jun 30, 2025 9.83%
Mar 31, 2025 -45.14%
Dec 31, 2024 10.71%
Sep 30, 2024 10.41%
Jun 30, 2024 10.87%
Mar 31, 2024 11.28%
Dec 31, 2023 11.64%
Sep 30, 2023 12.05%
Jun 30, 2023 11.98%
Mar 31, 2023 11.61%
Dec 31, 2022 11.48%
Sep 30, 2022 10.88%
Jun 30, 2022 10.65%
Mar 31, 2022 10.40%
Dec 31, 2021 9.90%
Sep 30, 2021 9.07%
Jun 30, 2021 8.55%
Mar 31, 2021 8.16%
Dec 31, 2020 6.33%
Sep 30, 2020 6.27%
Jun 30, 2020 4.57%
Mar 31, 2020 3.41%
Dec 31, 2019 1.71%
Sep 30, 2019 1.23%
Jun 30, 2019 -0.04%
Mar 31, 2019 -1.13%
Dec 31, 2018 -2.36%
Sep 30, 2018 -3.60%
Jun 30, 2018 -4.24%
Dec 31, 2017 -4.95%
Jun 30, 2017 -5.29%
Mar 31, 2017 -5.67%
Dec 31, 2016 -5.90%
Sep 30, 2016 -5.99%
Jun 30, 2016 -6.38%
Mar 31, 2016 -5.99%
Dec 31, 2015 -6.04%
Sep 30, 2015 -6.12%
Jun 30, 2015 -6.14%
Mar 31, 2015 -6.42%
Dec 31, 2014 -6.39%
Sep 30, 2014 14.18%
Jun 30, 2014 15.11%